Journal article
Measuring child development at the 2–2½-year health and development review in England: a rapid scoping review of available tools
- Abstract:
- Objective: All children in England should receive a health review at 2–2½ years, with the Ages and Stages Questionnaire third edition (ASQ-3) used to collect public health surveillance data on child development. However, practitioners also value tools that assess individual children’s development—consistent with ASQ-3’s original purpose. Concerns about licensing costs and barriers to digitalisation have prompted interest in alternative tools to the ASQ-3 in England. Design: To inform policy, we conducted a rapid scoping review following Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews guidelines to identify tools that can measure or assess early child development. Data sources: Searched PubMed, PsycINFO and Web of Science from January 2012 to November 2022, with targeted search update November 2024. Eligibility criteria: We included English-language studies published after January 2012 that described or evaluated tools in English which could measure or assess early child development in children <5 years across five domains: motor, cognitive, communicative, social and emotional. Data extraction: We extracted key features and reliability, validity, sensitivity and specificity of tools which could feasibly be implemented at the 2–2½-year review (eg, including multiple age versions and <30 min to use). We used Quality Assessment of Diagnostic Accuracy Studies-I to assess risk of bias. Results: We identified 112 unique publications describing 34 tools; six met our feasibility criteria for the 2–2½-year review (reported in 53 studies). Only ASQ-3 and CREDI offer domain-specific scoring—a government priority. ASQ-3 moderately detects mild delays and performs better for severe delays in at-risk groups. Caregiver Reported Early Development Instruments (CREDI) was designed for public health surveillance, and we do not yet know how it performs for individual assessment. Conclusions: ASQ-3 and CREDI are most promising for use at the 2–2½-year review. However, we lack UK-based validation and norming studies, even for ASQ-3. Ultimately, careful implementation and integration into existing systems will determine a tool’s value for identifying developmental needs, supporting families and producing high quality data for public health surveillance.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 631.6KB, Terms of use)
-
- Publisher copy:
- 10.1136/bmjopen-2025-102853
Authors
- Publisher:
- BMJ Publishing Group
- Journal:
- BMJ Open More from this journal
- Volume:
- 16
- Issue:
- 2
- Pages:
- e102853
- Article number:
- bmjopen-2025-102853
- Publication date:
- 2026-02-04
- Acceptance date:
- 2026-01-06
- DOI:
- EISSN:
-
2044-6055
- ISSN:
-
2044-6055
- Language:
-
English
- Keywords:
- Pubs id:
-
2370564
- Local pid:
-
pubs:2370564
- Source identifiers:
-
3748941
- Deposit date:
-
2026-02-11
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2026
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record